Overall rank by patents
#25,477
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 10 technology areas, active 2018–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H04N (PICTORIAL COMMUNICATION, e.g. TELEVISION).
The verdict
Virtek holds 11 US patents across 10 technology areas, rank #25,477 of 50,000 tracked assignees.
Virtek Vision International ULC has been granted 11 US utility patents between 2018 and 2022, placing Virtek Vision International ULC at rank #25,477 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.8 claims per patent with primary concentration in H04N (PICTORIAL COMMUNICATION, e.g. TELEVISION). As a Foreign Corporation, Virtek Vision International ULC is one of the more focused assignees in the PatentsView dataset. By volume, Virtek sits between Vicat (11 patents, rank #25,473) and Visunex Medical Systems Co. Ltd. (11 patents, rank #25,481) - the closest US assignees by grant volume. The composite Innovation Score of 29.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 5 in the 2015–2019 window, a +20% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Virtek Vision International ULC's 14.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Virtek Vision International ULC against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
VICAT
11 patents
VICTHOM LABORATORY INC.
11 patents
VICTORY GRIPS LLC
11 patents
VINFAST TRADING AND PRODUCTION LIMITED LIABILITY COMPANY
11 patents
VISIER SOLUTIONS, INC.
11 patents
VISIONARY VR, INC.
11 patents
VISIONAT INTERNATIONAL LIMITED
11 patents
VISUNEX MEDICAL SYSTEMS CO. LTD.
11 patents
VIRTEK VISION INTERNATIONAL ULC
11 patents
What this shows Virtek holds 11 patents at rank #25,477, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Virtek's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
29 Top 69% higher than 31% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 2 | 18.2% |
| 2019 | 3 | 27.3% |
| 2020 | 1 | 9.1% |
| 2021 | 4 | 36.4% |
| 2022 | 1 | 9.1% |
Top 10 of 10 technology areas
Overall rank by patents
#25,477
Across all tracked assignees
29.5 out of 100
How to use this portfolio
Virtek's 11 grants land it in the top 69% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.